CV Lattes
ORCID
Abstract
Cisplatin is a potent antitumoral drug for diverse tumor types. However, its nephrotoxic adverse effects limit its clinical use in cancer therapy. Faced with this, several non-pharmacological approaches have been studied to minimize cisplatin-induced renal inflammation. One of these non-pharmacological approaches is caloric restriction, which several studies have demonstrated to be effici…